QUARTERLY FINANCIAL STATEMENTS (UNAUDITED) (Details 3) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2019 |
Sep. 30, 2019 |
Dec. 31, 2019 |
Dec. 31, 2018 |
||||||||||||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES | |||||||||||||||||||||||||||||
Net loss | $ (18,361,000) | $ (53,478,000) | $ (54,842,000) | $ (72,587,000) | |||||||||||||||||||||||||
Adjustments to reconcile net loss to net cash flows used in operating activities | |||||||||||||||||||||||||||||
Depreciation and amortization | 54,000 | 73,000 | 61,000 | ||||||||||||||||||||||||||
Impairment loss on long-term investment | 524,000 | 515,000 | 0 | ||||||||||||||||||||||||||
Amortization of discount of notes payable and convertible notes payable | 21,875,000 | 23,781,000 | 18,234,000 | ||||||||||||||||||||||||||
Foreign exchange adjustments on convertible notes and notes payable | (207,000) | (115,000) | (297,000) | ||||||||||||||||||||||||||
Net losses on investment in marketable securities | 21,718,000 | 21,432,000 | 43,977,000 | ||||||||||||||||||||||||||
Loss on equity method investment | (36,000) | 413,000 | 414,000 | 97,000 | |||||||||||||||||||||||||
Loss on debt extinguishment | 438,000 | 438,000 | 438,000 | 2,702,000 | |||||||||||||||||||||||||
Share-based compensation and fair value of replacement equity award | 3,593,000 | 3,805,000 | 4,545,000 | ||||||||||||||||||||||||||
Notes conversion costs | 3,341,000 | 3,341,000 | 3,341,000 | ||||||||||||||||||||||||||
Change in fair value of warrant derivative liabilities | (3,576,000) | (3,492,000) | (3,545,000) | (4,476,000) | |||||||||||||||||||||||||
Change in fair value of embedded conversion option | (131,000) | (131,000) | (131,000) | ||||||||||||||||||||||||||
Net changes in operating assets and liabilities | |||||||||||||||||||||||||||||
Accounts receivable | (193,000) | (361,000) | (1,761,000) | ||||||||||||||||||||||||||
Inventories | (2,787,000) | (3,267,000) | (4,079,000) | ||||||||||||||||||||||||||
Prepaid expenses and other current assets | (1,025,000) | (720,000) | (332,000) | ||||||||||||||||||||||||||
Other non-current assets | (4,150,000) | (4,364,000) | (241,000) | ||||||||||||||||||||||||||
Accounts payable and accrued expenses | 5,966,000 | 6,527,000 | 3,572,000 | ||||||||||||||||||||||||||
Deferred revenue | 500,000 | ||||||||||||||||||||||||||||
Deferred rent | (287,000) | (317,000) | 245,000 | ||||||||||||||||||||||||||
Other current liabilities | 828,000 | 426,000 | 5,312,000 | ||||||||||||||||||||||||||
Other long-term liabilities | 2,363,000 | 2,451,000 | (630,000) | ||||||||||||||||||||||||||
Net cash flows used in operating activities | (4,137,000) | (4,523,000) | (5,634,000) | ||||||||||||||||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES | |||||||||||||||||||||||||||||
Cash paid in connection with the Merger | (1,641,000) | (1,645,000) | |||||||||||||||||||||||||||
Purchases of property and equipment | (55,000) | (60,000) | (94,000) | ||||||||||||||||||||||||||
Proceeds from sale of marketable securities | 221,000 | 221,000 | 6,439,000 | ||||||||||||||||||||||||||
Net cash flows used in investing activities | (1,475,000) | (1,484,000) | (7,440,000) | ||||||||||||||||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES | |||||||||||||||||||||||||||||
Payments of convertible notes | (3,368,000) | (5,348,000) | (20,000,000) | ||||||||||||||||||||||||||
Proceeds from exercise of warrants | 186,000 | 186,000 | 111,000 | ||||||||||||||||||||||||||
Proceeds from issuance of common stock | 6,210,000 | 8,589,000 | 1,275,000 | ||||||||||||||||||||||||||
Net cash flows provided by (used in) financing activities | 3,028,000 | 3,884,000 | (5,577,000) | ||||||||||||||||||||||||||
Effect of exchange rate changes on cash | 5,000 | (13,000) | |||||||||||||||||||||||||||
Net decrease in cash and cash equivalents | (2,579,000) | (2,136,000) | (18,651,000) | ||||||||||||||||||||||||||
Cash, cash equivalent, beginning of period | 3,905,000 | 3,905,000 | 22,556,000 | ||||||||||||||||||||||||||
Cash, cash equivalents, end of period | 1,326,000 | 1,326,000 | 1,769,000 | 3,905,000 | |||||||||||||||||||||||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW ACTIVITIES | |||||||||||||||||||||||||||||
Interest paid | 1,239,000 | 1,543,000 | 2,178,000 | ||||||||||||||||||||||||||
Income taxes paid | 242,000 | 227,000 | 3,000 | ||||||||||||||||||||||||||
Warrant liabilities reclassified to equity | 6,337,000 | 6,337,000 | |||||||||||||||||||||||||||
Conversion of convertible notes and notes payable to common stock | 33,777,000 | 33,777,000 | |||||||||||||||||||||||||||
Conversion of accrued interest payable to common stock | 2,381,000 | 5,722,000 | |||||||||||||||||||||||||||
Initial recognition of right-of-use lease asset | 2,922,000 | 2,922,000 | |||||||||||||||||||||||||||
Previously Reported [Member] | |||||||||||||||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES | |||||||||||||||||||||||||||||
Net loss | (26,083,000) | (59,563,000) | (58,044,000) | ||||||||||||||||||||||||||
Adjustments to reconcile net loss to net cash flows used in operating activities | |||||||||||||||||||||||||||||
Depreciation and amortization | 54,000 | 61,000 | |||||||||||||||||||||||||||
Impairment loss on long-term investment | 524,000 | ||||||||||||||||||||||||||||
Amortization of discount of notes payable and convertible notes payable | 19,479,000 | 18,263,000 | |||||||||||||||||||||||||||
Foreign exchange adjustments on convertible notes and notes payable | 49,000 | 53,000 | |||||||||||||||||||||||||||
Net losses on investment in marketable securities | 21,718,000 | 43,977,000 | |||||||||||||||||||||||||||
Loss on equity method investment | 0 | ||||||||||||||||||||||||||||
Loss on debt extinguishment | 6,427,000 | 6,427,000 | 3,245,000 | ||||||||||||||||||||||||||
Share-based compensation and fair value of replacement equity award | 3,541,000 | 4,597,000 | |||||||||||||||||||||||||||
Notes conversion costs | 3,906,000 | 3,906,000 | |||||||||||||||||||||||||||
Change in fair value of warrant derivative liabilities | (424,000) | (623,000) | (20,674,000) | ||||||||||||||||||||||||||
Change in fair value of embedded conversion option | (342,000) | (342,000) | (466,000) | ||||||||||||||||||||||||||
Net changes in operating assets and liabilities | |||||||||||||||||||||||||||||
Accounts receivable | (548,000) | (1,324,000) | |||||||||||||||||||||||||||
Inventories | (2,787,000) | (4,079,000) | |||||||||||||||||||||||||||
Prepaid expenses and other current assets | (426,000) | (431,000) | |||||||||||||||||||||||||||
Other non-current assets | (4,150,000) | (241,000) | |||||||||||||||||||||||||||
Accounts payable and accrued expenses | 4,857,000 | 4,631,000 | |||||||||||||||||||||||||||
Deferred revenue | 500,000 | ||||||||||||||||||||||||||||
Deferred rent | (287,000) | 245,000 | |||||||||||||||||||||||||||
Other current liabilities | 230,000 | 5,174,000 | |||||||||||||||||||||||||||
Other long-term liabilities | 2,363,000 | (630,000) | |||||||||||||||||||||||||||
Net cash flows used in operating activities | (5,078,000) | (5,653,000) | |||||||||||||||||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES | |||||||||||||||||||||||||||||
Cash paid in connection with the Merger | (1,641,000) | ||||||||||||||||||||||||||||
Purchases of property and equipment | (55,000) | (94,000) | |||||||||||||||||||||||||||
Proceeds from sale of marketable securities | 221,000 | 6,439,000 | |||||||||||||||||||||||||||
Net cash flows used in investing activities | (1,475,000) | 5,876,000 | |||||||||||||||||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES | |||||||||||||||||||||||||||||
Payments of convertible notes | (3,368,000) | (20,000,000) | |||||||||||||||||||||||||||
Proceeds from exercise of warrants | 186,000 | 111,000 | |||||||||||||||||||||||||||
Proceeds from issuance of common stock | 6,210,000 | 1,275,000 | |||||||||||||||||||||||||||
Net cash flows provided by (used in) financing activities | 3,028,000 | (5,700,000) | |||||||||||||||||||||||||||
Effect of exchange rate changes on cash | (8,000) | ||||||||||||||||||||||||||||
Net decrease in cash and cash equivalents | (3,533,000) | (5,477,000) | |||||||||||||||||||||||||||
Cash, cash equivalent, beginning of period | 17,079,000 | 17,079,000 | 22,556,000 | ||||||||||||||||||||||||||
Cash, cash equivalents, end of period | 13,546,000 | 13,546,000 | 17,079,000 | ||||||||||||||||||||||||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW ACTIVITIES | |||||||||||||||||||||||||||||
Interest paid | 1,239,000 | 2,178,000 | |||||||||||||||||||||||||||
Income taxes paid | 242,000 | 3,000 | |||||||||||||||||||||||||||
Warrant liabilities reclassified to equity | 776,000 | ||||||||||||||||||||||||||||
Conversion of convertible notes and notes payable to common stock | 33,777,000 | ||||||||||||||||||||||||||||
Conversion of accrued interest payable to common stock | 2,381,000 | ||||||||||||||||||||||||||||
Adjustments [Member] | |||||||||||||||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES | |||||||||||||||||||||||||||||
Net loss | 7,722,000 | 6,085,000 | (14,543,000) | ||||||||||||||||||||||||||
Adjustments to reconcile net loss to net cash flows used in operating activities | |||||||||||||||||||||||||||||
Amortization of discount of notes payable and convertible notes payable | 2,396,000 | (29,000) | [1] | ||||||||||||||||||||||||||
Foreign exchange adjustments on convertible notes and notes payable | (256,000) | (350,000) | |||||||||||||||||||||||||||
Loss on equity method investment | (36,000) | [2] | 413,000 | [3] | 97,000 | [4] | |||||||||||||||||||||||
Loss on debt extinguishment | (5,989,000) | [5],[6] | (5,989,000) | [7],[8] | (543,000) | [1],[9] | |||||||||||||||||||||||
Share-based compensation and fair value of replacement equity award | 52,000 | (52,000) | [1] | ||||||||||||||||||||||||||
Notes conversion costs | (565,000) | [5] | (565,000) | [7] | |||||||||||||||||||||||||
Change in fair value of warrant derivative liabilities | (3,152,000) | [5],[6] | (2,869,000) | [7],[8] | 16,198,000 | [10],[11] | |||||||||||||||||||||||
Change in fair value of embedded conversion option | 211,000 | [6] | 211,000 | [8] | 466,000 | [1],[9] | |||||||||||||||||||||||
Net changes in operating assets and liabilities | |||||||||||||||||||||||||||||
Accounts receivable | 355,000 | (437,000) | [1] | ||||||||||||||||||||||||||
Prepaid expenses and other current assets | (599,000) | 99,000 | [1] | ||||||||||||||||||||||||||
Accounts payable and accrued expenses | 1,109,000 | (1,059,000) | [1] | ||||||||||||||||||||||||||
Other current liabilities | 598,000 | 138,000 | [1] | ||||||||||||||||||||||||||
Net cash flows used in operating activities | 941,000 | 19,000 | |||||||||||||||||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES | |||||||||||||||||||||||||||||
Net cash flows used in investing activities | (13,316,000) | ||||||||||||||||||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES | |||||||||||||||||||||||||||||
Net cash flows provided by (used in) financing activities | 123,000 | ||||||||||||||||||||||||||||
Effect of exchange rate changes on cash | 13,000 | ||||||||||||||||||||||||||||
Net decrease in cash and cash equivalents | 954,000 | (13,174,000) | |||||||||||||||||||||||||||
Cash, cash equivalent, beginning of period | (13,174,000) | $ (13,174,000) | |||||||||||||||||||||||||||
Cash, cash equivalents, end of period | $ (12,220,000) | (12,220,000) | $ (13,174,000) | ||||||||||||||||||||||||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW ACTIVITIES | |||||||||||||||||||||||||||||
Warrant liabilities reclassified to equity | 5,561,000 | ||||||||||||||||||||||||||||
Initial recognition of right-of-use lease asset | $ 2,922,000 | ||||||||||||||||||||||||||||
|